[Effect of a bovine surfactant in very low birth weight premature infants with congenital pneumonia]
- PMID: 2377170
[Effect of a bovine surfactant in very low birth weight premature infants with congenital pneumonia]
Abstract
15 VLBW-infants, who were classified to suffer from congenital pneumonia, were treated with a bovine surfactant. Mean gestational age was 25.5 weeks (range 23-27 weeks), mean birth weight was 700 g (range 530-930 g). Surfactant was instilled intratracheally at a mean dose of 41 mg/kg body weight (b.w.) (range 30-50 mg) 8 h after birth (range 6-12 h), if the fraction of inspired oxygen (FiO2) was greater than 0.5 or the peak inspiratory pressure (PIP) was greater than 22 cm H2O (b.w. less than 750 g) or greater than 25 cm H2O (b.w. 751-1000 g). Retreatment up to a total maximum of 4 doses of surfactant was permitted. Surfactant treatment reduced FiO2 from a pretreatment value of 0.79 to 0.50 one hour after application, however, 12 h later FiO2 had increased again to 0.75. Ventilation pressures showed a slight decrease during 12 h after surfactant treatment. 6 infants received 1 dose, multiple doses were given to 9 infants. 5 infants survived, 4 infants died from respiratory failure, 4 from sepsis and 2 from severe intracranial haemorrhage.
Similar articles
-
[Treatment of respiratory distress syndrome in very small premature infants with bovine surfactant].Monatsschr Kinderheilkd. 1990 Jan;138(1):8-12. Monatsschr Kinderheilkd. 1990. PMID: 2314405 Clinical Trial. German.
-
[The effect of bovine surfactant in premature infants with respiratory distress syndrome. Results of an open, multicenter study].Z Geburtshilfe Perinatol. 1992 Jul-Aug;196(4):159-64. Z Geburtshilfe Perinatol. 1992. PMID: 1413943 Clinical Trial. German.
-
Repeat surfactant therapy for postsurfactant slump.J Perinatol. 2006 Jul;26(7):414-22. doi: 10.1038/sj.jp.7211533. Epub 2006 May 18. J Perinatol. 2006. PMID: 16724122
-
Natural surfactant for neonatal respiratory distress syndrome in very premature infants: a 1992 update.J Perinat Med. 1992;20(6):409-19. doi: 10.1515/jpme.1992.20.6.409. J Perinat Med. 1992. PMID: 1293266 Review.
-
[Progress in the care of very low birth-weight infants].Nihon Sanka Fujinka Gakkai Zasshi. 1988 Feb;40(2):231-7. Nihon Sanka Fujinka Gakkai Zasshi. 1988. PMID: 3283271 Review. Japanese. No abstract available.
Cited by
-
Surfactant replacement therapy for non-respiratory distress syndrome neonatal respiratory disease--research or clinical application?Eur J Pediatr. 1995;154(8 Suppl 3):S2-4. doi: 10.1007/BF02155101. Eur J Pediatr. 1995. PMID: 7588985 Free PMC article.
-
Pulmonary surfactant as vehicle for intratracheally instilled tobramycin in mice infected with Klebsiella pneumoniae.Br J Pharmacol. 1996 Nov;119(6):1145-8. doi: 10.1111/j.1476-5381.1996.tb16016.x. Br J Pharmacol. 1996. PMID: 8937717 Free PMC article.
-
In vivo effect of pneumonia on surfactant disaturated-phosphatidylcholine kinetics in newborn infants.PLoS One. 2014 Dec 31;9(12):e93612. doi: 10.1371/journal.pone.0093612. eCollection 2014. PLoS One. 2014. PMID: 25551219 Free PMC article.
-
Can surfactants affect mortality and morbidity in term infants with respiratory failure?Turk J Med Sci. 2022 Dec;52(6):1779-1784. doi: 10.55730/1300-0144.5523. Epub 2022 Dec 21. Turk J Med Sci. 2022. PMID: 36945972 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical